{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:25:00Z","timestamp":1794666300694,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08387-1","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:48:29Z","timestamp":1784112509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of vascular endothelial growth factor (VEGF) in major depressive disorder: an update meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"5","key":"8387_CR1","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1038\/tp.2016.79","volume":"6","author":"SH Mellon","year":"2016","unstructured":"Mellon SH, Wolkowitz OM, Schonemann MD, Epel ES, Rosser R, Burke HB, et al. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. Transl Psychiatry. 2016;6(5):e821.","journal-title":"Transl Psychiatry"},{"key":"8387_CR2","doi-asserted-by":"publisher","first-page":"703965","DOI":"10.3389\/fphar.2021.703965","volume":"12","author":"W Yan","year":"2021","unstructured":"Yan W, Dong Z, Zhao D, Li J, Zeng T, Mo C, et al. Xiaoyaosan Exerts Antidepressant Effect by Downregulating RAGE Expression in Cingulate Gyrus of Depressive-Like Mice. Front Pharmacol. 2021;12:703965.","journal-title":"Front Pharmacol"},{"key":"8387_CR3","doi-asserted-by":"publisher","first-page":"586879","DOI":"10.3389\/fphar.2020.586879","volume":"11","author":"YY Yin","year":"2020","unstructured":"Yin YY, Tian CY, Fang XX, Shang C, Zhang LM, Xu Q, et al. The Faster-Onset Antidepressant Effects of Hypidone Hydrochloride (YL-0919) in Monkeys Subjected to Chronic Unpredictable Stress. Front Pharmacol. 2020;11:586879.","journal-title":"Front Pharmacol"},{"issue":"8","key":"8387_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1242\/dev.072348","volume":"139","author":"F Mackenzie","year":"2012","unstructured":"Mackenzie F, Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development. 2012;139(8):1371\u201380.","journal-title":"Development"},{"issue":"7","key":"8387_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/ijnp\/pyaa021","volume":"23","author":"F Chen","year":"2020","unstructured":"Chen F, Danladi J, Wegener G, Madsen TM, Nyengaard JR. Sustained Ultrastructural Changes in Rat Hippocampal Formation After Repeated Electroconvulsive Seizures. Int J Neuropsychopharmacol. 2020;23(7):446\u201358.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"8387_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1172\/JCI200317977","volume":"111","author":"Y Sun","year":"2003","unstructured":"Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111(12):1843\u201351.","journal-title":"J Clin Invest"},{"key":"8387_CR7","doi-asserted-by":"publisher","first-page":"tkab033","DOI":"10.1093\/burnst\/tkab033","volume":"9","author":"X Lei","year":"2021","unstructured":"Lei X, Cheng L, Yang Y, Pang M, Dong Y, Zhu X, et al. Co-administration of platelet-rich plasma and small intestinal submucosa is more beneficial than their individual use in promoting acute skin wound healing. Burns Trauma. 2021;9:tkab033.","journal-title":"Burns Trauma"},{"key":"8387_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fphar.2019.01544","volume":"10","author":"K Fang","year":"2019","unstructured":"Fang K, Li HR, Chen XX, Gao XR, Huang LL, Du AQ, et al. Quercetin Alleviates LPS-Induced Depression-Like Behavior in Rats via Regulating BDNF-Related Imbalance of Copine 6 and TREM1\/2 in the Hippocampus and PFC. Front Pharmacol. 2019;10:1544.","journal-title":"Front Pharmacol"},{"issue":"6","key":"8387_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/bjophthalmol-2018-312318","volume":"103","author":"I Mantel","year":"2019","unstructured":"Mantel I, Zola M, Mir O, Gaillard R, Behar-Cohen F. Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration. Br J Ophthalmol. 2019;103(6):811\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"1\u20132","key":"8387_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainresbull.2011.06.003","volume":"86","author":"L Ibrahim","year":"2011","unstructured":"Ibrahim L, Duncan W, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA. Jr. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull. 2011;86(1\u20132):129\u201333.","journal-title":"Brain Res Bull"},{"issue":"2","key":"8387_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jad.2013.06.055","volume":"151","author":"M Fornaro","year":"2013","unstructured":"Fornaro M, Rocchi G, Escelsior A, Contini P, Ghio M, Colicchio S, et al. VEGF plasma level variations in duloxetine-treated patients with major depression. J Affect Disord. 2013;151(2):590\u20135.","journal-title":"J Affect Disord"},{"issue":"4","key":"8387_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.neuron.2007.05.002","volume":"54","author":"S Ge","year":"2007","unstructured":"Ge S, Yang CH, Hsu KS, Ming GL, Song H. A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron. 2007;54(4):559\u201366.","journal-title":"Neuron"},{"issue":"12","key":"8387_CR13","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1523\/JNEUROSCI.4941-06.2007","volume":"27","author":"A Tashiro","year":"2007","unstructured":"Tashiro A, Makino H, Gage FH. Experience-specific functional modification of the dentate gyrus through adult neurogenesis: a critical period during an immature stage. J Neurosci. 2007;27(12):3252\u20139.","journal-title":"J Neurosci"},{"issue":"3","key":"8387_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nn1847","volume":"10","author":"N Kee","year":"2007","unstructured":"Kee N, Teixeira CM, Wang AH, Frankland PW. Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat Neurosci. 2007;10(3):355\u201362.","journal-title":"Nat Neurosci"},{"issue":"12","key":"8387_CR15","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1073\/pnas.1007640108","volume":"108","author":"T Licht","year":"2011","unstructured":"Licht T, Goshen I, Avital A, Kreisel T, Zubedat S, Eavri R, et al. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci U S A. 2011;108(12):5081\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8387_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coph.2019.11.009","volume":"50","author":"B Planchez","year":"2020","unstructured":"Planchez B, Surget A, Belzung C. Adult hippocampal neurogenesis and antidepressants effects. Curr Opin Pharmacol. 2020;50:88\u201395.","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"8387_CR17","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41380-022-01618-3","volume":"27","author":"H Matsuno","year":"2022","unstructured":"Matsuno H, Tsuchimine S, O\u2019Hashi K, Sakai K, Hattori K, Hidese S, et al. Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression. Mol Psychiatry. 2022;27(9):3822\u201332.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"8387_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0164-4","volume":"50","author":"YQ Wan","year":"2018","unstructured":"Wan YQ, Feng JG, Li M, Wang MZ, Liu L, Liu X, et al. Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats. Exp Mol Med. 2018;50(10):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"1","key":"8387_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","volume":"46","author":"MM Nowacka","year":"2012","unstructured":"Nowacka MM, Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides. 2012;46(1):1\u201310.","journal-title":"Neuropeptides"},{"issue":"11","key":"8387_CR20","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/npp.2009.68","volume":"34","author":"J Greene","year":"2009","unstructured":"Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology. 2009;34(11):2459\u201368.","journal-title":"Neuropsychopharmacology"},{"key":"8387_CR21","doi-asserted-by":"publisher","first-page":"112781","DOI":"10.1016\/j.psychres.2020.112781","volume":"284","author":"MFR Castillo","year":"2020","unstructured":"Castillo MFR, Cohen A, Edberg D, Hoppensteadt D, Fareed J, Martin B, et al. Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction. Psychiatry Res. 2020;284:112781.","journal-title":"Psychiatry Res"},{"issue":"4","key":"8387_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3","volume":"425","author":"TD Palmer","year":"2000","unstructured":"Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000;425(4):479\u201394.","journal-title":"J Comp Neurol"},{"issue":"8","key":"8387_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","volume":"12","author":"C Lange","year":"2016","unstructured":"Lange C, Storkebaum E, de Almod\u00f3var CR, Dewerchin M, Carmeliet P. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol. 2016;12(8):439\u201354.","journal-title":"Nat Rev Neurol"},{"issue":"1\u20132","key":"8387_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jad.2011.07.021","volume":"136","author":"BH Lee","year":"2012","unstructured":"Lee BH, Kim YK. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord. 2012;136(1\u20132):181\u20134.","journal-title":"J Affect Disord"},{"issue":"6","key":"8387_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/acps.12187","volume":"129","author":"A Minelli","year":"2014","unstructured":"Minelli A, Maffioletti E, Bortolomasi M, Conca A, Zanardini R, Rillosi L, et al. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. Acta Psychiatr Scand. 2014;129(6):461\u20136.","journal-title":"Acta Psychiatr Scand"},{"issue":"53","key":"8387_CR26","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.1523\/JNEUROSCI.3673-08.2008","volume":"28","author":"H Udo","year":"2008","unstructured":"Udo H, Yoshida Y, Kino T, Ohnuki K, Mizunoya W, Mukuda T, et al. Enhanced adult neurogenesis and angiogenesis and altered affective behaviors in mice overexpressing vascular endothelial growth factor 120. J Neurosci. 2008;28(53):14522\u201336.","journal-title":"J Neurosci"},{"issue":"3","key":"8387_CR27","first-page":"247","volume":"20","author":"M Ardalan","year":"2017","unstructured":"Ardalan M, Wegener G, Rafati AH, Nyengaard JR. S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression. Int J Neuropsychopharmacol. 2017;20(3):247\u201356.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"8387_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"8387_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-171042","volume":"62","author":"AD Smith","year":"2018","unstructured":"Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, et al. Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis. 2018;62(2):561\u201370.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"8387_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","volume":"64","author":"JO Friedrich","year":"2011","unstructured":"Friedrich JO, Adhikari NK, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. 2011;64(5):556\u201364.","journal-title":"J Clin Epidemiol"},{"key":"8387_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpsychires.2014.08.005","volume":"59","author":"A Clark-Raymond","year":"2014","unstructured":"Clark-Raymond A, Meresh E, Hoppensteadt D, Fareed J, Sinacore J, Halaris A. Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression. J Psychiatr Res. 2014;59:22\u20137.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"8387_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.mp.4002138","volume":"14","author":"P Dome","year":"2008","unstructured":"Dome P, Teleki Z, Rihmer Z, Peter L, Dobos J, Kenessey I, et al. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry. 2008;14(5):523\u201331.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"8387_CR33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1017\/S1461145714000273","volume":"17","author":"B Elfving","year":"2014","unstructured":"Elfving B, Buttensch\u00f8n HN, Foldager L, Poulsen PH, Grynderup MB, Hansen \u00c5M, et al. Depression and BMI influences the serum vascular endothelial growth factor level. Int J Neuropsychopharmacol. 2014;17(9):1409\u201317.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8387_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2013.04.011","volume":"45","author":"P Galecki","year":"2013","unstructured":"Galecki P, Galecka E, Maes M, Orzechowska A, Berent D, Talarowska M, et al. Vascular endothelial growth factor gene (<\u2009i>VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuro-psychopharmacol Biol Psychiatry. 2013;45:117\u201324.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"8387_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/NDT.S350121","volume":"18","author":"T Hoshikawa","year":"2022","unstructured":"Hoshikawa T, Okamoto N, Natsuyanna T, Fujii R, Ikenouchi A, Honma Y, et al. Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation. Neuropsychiatr Dis Treat. 2022;18:173\u201386.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"8387_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.psyneuen.2008.09.016","volume":"34","author":"KG Kahl","year":"2009","unstructured":"Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, et al. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology. 2009;34(3):353\u20137.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"8387_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/2045125312436572","volume":"2","author":"Z Kotan","year":"2012","unstructured":"Kotan Z, Sarand\u00f6l E, K\u0131rhan E, Ozkaya G, K\u0131rl\u0131 S. Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. Ther Adv Psychopharmacol. 2012;2(2):65\u201374.","journal-title":"Ther Adv Psychopharmacol"},{"key":"8387_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jad.2024.09.073","volume":"368","author":"K Li","year":"2025","unstructured":"Li K, Wang K, Xu S-x, Xie X-h, Tang Y, Zhang L, et al. In vivo evidence of increased vascular endothelial growth factor in patients with major depressive disorder. J Affect Disord. 2025;368:151\u20139.","journal-title":"J Affect Disord"},{"issue":"7","key":"8387_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.comppsych.2013.03.026","volume":"54","author":"S Lu","year":"2013","unstructured":"Lu S, Peng H, Wang L, Vasisha S, Zhang Y, Gao W, et al. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: A cytokine antibody array analysis. Compr Psychiatr. 2013;54(7):953\u201361.","journal-title":"Compr Psychiatr"},{"issue":"4","key":"8387_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0004867419893433","volume":"54","author":"A Rigal","year":"2020","unstructured":"Rigal A, Colle R, El Asmar K, Trabado S, Loeb E, Martin S, et al. Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study. Aust N Z J Psychiatry. 2020;54(4):402\u20138.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"8387_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/PSY.0b013e318164231d","volume":"70","author":"U Schweiger","year":"2008","unstructured":"Schweiger U, Greggersen W, Rudolf S, Pusch M, Menzel T, Winn S, et al. Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique. Psychosom Med. 2008;70(2):170\u20136.","journal-title":"Psychosom Med"},{"issue":"9","key":"8387_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00702-010-0452-1","volume":"117","author":"M Takebayashi","year":"2010","unstructured":"Takebayashi M, Hashimoto R, Hisaoka K, Tsuchioka M, Kunugi H. Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J Neural Transm (Vienna). 2010;117(9):1119\u201322.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"8387_CR43","doi-asserted-by":"publisher","first-page":"16693","DOI":"10.1038\/s41598-021-96313-8","volume":"11","author":"J Wallensten","year":"2021","unstructured":"Wallensten J, Mobarrez F, \u00c5sberg M, Borg K, Beser A, Wilczek A, et al. Isoforms of soluble vascular endothelial growth factor in stress-related mental disorders: a cross-sectional study. Sci Rep. 2021;11(1):16693.","journal-title":"Sci Rep"},{"issue":"4","key":"8387_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0004867419893433","volume":"54","author":"A Rigal","year":"2020","unstructured":"Rigal A, Colle R, Asmar KE, Trabado S, Loeb E, Martin S, et al. Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study. Aust N Z J Psychiatry. 2020;54(4):402\u20138.","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"8387_CR45","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00406-019-01086-x","volume":"270","author":"L Kranaster","year":"2020","unstructured":"Kranaster L, Hoyer C, Mindt S, Neumaier M, M\u00fcller N, Zill P, et al. The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid. Eur Arch Psychiatry Clin Neurosci. 2020;270(7):911\u20139.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8387_CR46","doi-asserted-by":"publisher","first-page":"806731","DOI":"10.3389\/fpsyt.2022.806731","volume":"13","author":"M Elemery","year":"2022","unstructured":"Elemery M, Kiss S, Dome P, Pogany L, Faludi G, Lazary J. Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation. Front Psychiatry. 2022;13:806731.","journal-title":"Front Psychiatry"},{"key":"8387_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","volume":"88","author":"N \u00c7akici","year":"2020","unstructured":"\u00c7akici N, Sutterland AL, Penninx B, Dalm VA, de Haan L, van Beveren NJM. Altered peripheral blood compounds in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Brain Behav Immun. 2020;88:547\u201358.","journal-title":"Brain Behav Immun"},{"key":"8387_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","volume":"41","author":"Y Shi","year":"2020","unstructured":"Shi Y, Luan D, Song R, Zhang Z. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2020;41:40\u201351.","journal-title":"Eur Neuropsychopharmacol"},{"key":"8387_CR49","doi-asserted-by":"publisher","first-page":"113319","DOI":"10.1016\/j.psychres.2020.113319","volume":"292","author":"J Pu","year":"2020","unstructured":"Pu J, Liu Y, Gui S, Tian L, Xu S, Song X, et al. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis. Psychiatry Res. 2020;292:113319.","journal-title":"Psychiatry Res"},{"issue":"1","key":"8387_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-025-01128-8","volume":"32","author":"B Aksan","year":"2025","unstructured":"Aksan B, Mauceri D. Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure. J Biomed Sci. 2025;32(1):33.","journal-title":"J Biomed Sci"},{"issue":"3","key":"8387_CR51","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s12035-014-8830-6","volume":"51","author":"T Ishrat","year":"2015","unstructured":"Ishrat T, Pillai B, Soliman S, Fouda AY, Kozak A, Johnson MH, et al. Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats. Mol Neurobiol. 2015;51(3):1542\u201353.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"8387_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ydbio.2019.11.016","volume":"459","author":"K Okabe","year":"2020","unstructured":"Okabe K, Fukada H, Tai-Nagara I, Ando T, Honda T, Nakajima K, et al. Neuron-derived VEGF contributes to cortical and hippocampal development independently of VEGFR1\/2-mediated neurotrophism. Dev Biol. 2020;459(2):65\u201371.","journal-title":"Dev Biol"},{"issue":"10","key":"8387_CR53","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2003.03041.x","volume":"18","author":"K Fabel","year":"2003","unstructured":"Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci. 2003;18(10):2803\u201312.","journal-title":"Eur J Neurosci"},{"key":"8387_CR54","doi-asserted-by":"crossref","unstructured":"Grossert A, Mehrjardi NZ, Bailey SJ, Lindsay MA, Hescheler J, \u0160ari\u0107 T et al. Ketamine increases proliferation of human iPSC-derived neuronal progenitor cells via insulin-like growth factor 2 and independent of the NMDA receptor. Cells. 2019;8(10).","DOI":"10.3390\/cells8101139"},{"issue":"12","key":"8387_CR55","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/mp.2015.195","volume":"21","author":"P De Rossi","year":"2016","unstructured":"De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, et al. A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior. Mol Psychiatry. 2016;21(12):1768\u201380.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"8387_CR56","doi-asserted-by":"publisher","first-page":"109121","DOI":"10.1016\/j.celrep.2021.109121","volume":"35","author":"L Martin","year":"2021","unstructured":"Martin L, Bouvet P, Chounlamountri N, Watrin C, Besan\u00e7on R, Pinatel D, et al. VEGF counteracts amyloid-\u03b2-induced synaptic dysfunction. Cell Rep. 2021;35(6):109121.","journal-title":"Cell Rep"},{"issue":"3","key":"8387_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/CIRCRESAHA.117.311983","volume":"122","author":"C Fu","year":"2018","unstructured":"Fu C, Tyagi R, Chin AC, Rojas T, Li RJ, Guha P, et al. Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1\u03b1 Degradation. Circ Res. 2018;122(3):457\u201372.","journal-title":"Circ Res"},{"issue":"8","key":"8387_CR58","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.18632\/oncotarget.7225","volume":"7","author":"G Sannino","year":"2016","unstructured":"Sannino G, Pasqualini L, Ricciardelli E, Montilla P, Soverchia L, Ruggeri B, et al. Acute stress enhances the expression of neuroprotection- and neurogenesis-associated genes in the hippocampus of a mouse restraint model. Oncotarget. 2016;7(8):8455\u201365.","journal-title":"Oncotarget"},{"issue":"5","key":"8387_CR59","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1460-9568.2005.03951.x","volume":"21","author":"VM Heine","year":"2005","unstructured":"Heine VM, Zareno J, Maslam S, Jo\u00ebls M, Lucassen PJ. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci. 2005;21(5):1304\u201314.","journal-title":"Eur J Neurosci"},{"key":"8387_CR60","doi-asserted-by":"crossref","unstructured":"Leschik J, Lutz B, Gentile A. Stress-related dysfunction of adult hippocampal neurogenesis-an attempt for understanding resilience? Int J Mol Sci. 2021;22(14).","DOI":"10.3390\/ijms22147339"},{"issue":"3","key":"8387_CR61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1734-1140(13)71031-4","volume":"65","author":"M Nowacka","year":"2013","unstructured":"Nowacka M, Obuchowicz E. BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep. 2013;65(3):535\u201346.","journal-title":"Pharmacol Rep"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08387-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:45:17Z","timestamp":1791517517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8387"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08387-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"775"}}